Home | Industry | Healthcare
Following the successful launch of the DocCheck® Faces network in Germany, DocCheck (GER:AJ9), the leading community for medical professionals in Europe, is now making its social networking package available in other countries. The Italian version is already online. English, Spanish and French versions will follow in January 2008. The English version is also aimed at the US market. Within DocCheck Faces, medical practitioners can put their profile on show, set up their own forums and exchange news with colleagues. In addition to the new community, services such as DocCheck Litbot (a program for managing medical publications) and the English-language DocCheck e-journal will be available to US physicians. “Our aim is to establish a global community of healthcare professionals, thereby significantly improving international exchanges between physicians”, explains Dr. Frank Antwerpes, DocCheck’s CEO. Over half a million registered users worldwide With over 500,000 users, DocCheck is one of the most heavily subscribed medical portals in the world. Around 8,000 new DocCheck users register each month. While growth was primarily concentrated in Europe up to 2006, the number of users outside the EU has increased disproportionately in recent months. Already one in two physicians in Germany, where the community was first introduced, is a member of DocCheck. DocCheck Medical Services GmbH With over 500,000 registered members, DocCheck is the largest and fastest-growing B2B community for medical professionals in Europe. Their password system is used to control access to over 1,700 websites of market-leading pharmaceutical companies in Germany. Online market research, eMarketing, and Customer Relationship Management (CRM) lie at the heart of DocCheck’s business model. Furthermore, the link to DocCheck Shop offers all members an eCommerce platform for the online purchase of over 15,000 items. DocCheck is a 100% owned subsidiary of DocCheck AG.
Article Source: http://www.share.onlypunjab.com
Please Rate this Article
5 out of 54 out of 53 out of 52 out of 51 out of 5
Not yet Rated
